Ambu A/S, commonly referred to as Ambu, is a leading global provider of innovative medical devices headquartered in Denmark (DK). Founded in 1937, the company has established a strong presence in the healthcare industry, particularly in the fields of anaesthesia, patient monitoring, and emergency care.
Ambu is renowned for its unique single-use endoscopy solutions and advanced airway management products, which enhance patient safety and streamline clinical workflows. With a commitment to quality and innovation, Ambu has achieved significant milestones, including the launch of its groundbreaking Ambu® aScope™.
Today, Ambu operates in key markets across Europe, North America, and Asia, solidifying its position as a trusted partner in the medical community. The company’s dedication to improving patient outcomes and its robust product portfolio have earned it a notable reputation in the healthcare sector.
+53 vs industry average
Ambu’s score of 80 is higher than 90% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Ambu?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 18% since 2019
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Ambu's reported carbon emissions
In 2025, Ambu A/S reported total carbon emissions of approximately 164.2 million kg CO2e, comprising 3,165,000 kg CO2e from Scope 1, 10,884,000 kg CO2e from Scope 2 (market-based), and 150,230,000 kg CO2e from Scope 3 emissions. This reflects a slight decrease from 2024, where total emissions were about 169.3 million kg CO2e. The company has set ambitious climate commitments, aiming for a 75% reduction in absolute Scope 1 and 2 greenhouse gas emissions by FY2030, using FY2021 as the baseline. Additionally, Ambu is committed to ensuring that 82% of its suppliers, by emissions, will have science-based targets by FY2027. Furthermore, the company has pledged to achieve net-zero emissions across all scopes by 2045. These targets align with the Science Based Targets initiative (SBTi) and demonstrate Ambu's commitment to sustainable practices in the healthcare equipment and supplies sector.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Ambu’s Climate Goals (2030 & 2050)
1 goal2045
Ambu’s as a business with support of its executive managemen…
Ambu’s as a business with support of its executive management committed to reaching net-zero targets by 2045.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 1 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
9 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Ambu’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project